Aldéric Fraslin on Muck Rack

Aldéric Fraslin

As seen in: BMJ Open, Value in Health Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aldéric

Contact Aldéric, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cost-Utility Analysis Alongside the GORTEC 2014-01 TPExtreme trial – Author Response to Letter to the Editor

|
By Aldéric Fraslin, Gustave Roussy, Anne Auperin
| Value in Health Journal Verified
Copyright: © 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.
Open in Who Shared Issue with article?

Cohort profile: COBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life

|
By Thierry Lebret, Julia Bonastre, Yann Neuzillet, Aldéric Fraslin
| BMJ Open Verified
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. EPIDEMIOLOGY Urological tumours Prognosis The COBLAnCE cohort includes 1800 patients with extensive data recorded for the primary tumour and for all subsequent recurrences.
Open in Who Shared View Duplicates (2) Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified